Taiwan FDA registration 75ecb57471e8a46bc360191b692eba54
"Siemens" glucose has been glycokinized per _3 reagent
TW: “西門子”葡萄糖已糖激每_3試劑
Taiwan·Risk Class 2·RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Oct 26, 2011 – Oct 26, 2026ActiveRegistration details
- Analysis ID
- 75ecb57471e8a46bc360191b692eba54
- Customs Code
- DHA00602273401
Company information
- Manufacturer Country
- United Kingdom;;United States
- Authorized Representative
- SIEMENS HEALTHCARE LIMITED
Product details
- Intended Use
- This product is used with ADVIA chemical analysis system to quantitatively determine the glucose concentration in human serum, cerebrospinal fluid, plasma and urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Oct 26, 2011
- Expiry Date
- Oct 26, 2026
About this record
Access comprehensive regulatory information for "Siemens" glucose has been glycokinized per _3 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 75ecb57471e8a46bc360191b692eba54 and manufactured by RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices